l9n/ Oregon

2017 Regular Session

House Bill 2386

Directs each manufacturer of certain types of drugs that are sold within this state to develop and implement drug take-back program for purpose of collecting from individuals and nonbusiness entities those types of drugs for disposal.

Did not become law. It stopped in the House of Representatives's Health Care Committee on July 7, 2017. The 2017 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Directs each manufacturer of certain types of drugs that are sold within this state to develop and implement drug take-back program for purpose of collecting from individuals and nonbusiness entities those types of drugs for disposal. Directs State Board of Pharmacy to administer Act. Requires manufacturers subject to Act to first submit plan for developing and implementing drug take-back program on or before December 31, 2018. Becomes operative January 1, 2018. Takes effect on 91st day following adjournment sine die.

Its course

January 9 to July 7, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action4 actions on 4 days

In the House of RepresentativesJan 9 to Jul 7 · stopped179 days

Waiting for a committeeJan 9 to Jan 178 days

Health CareJan 17 to Jul 7 · stopped171 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Jan 9 – Jul 7

  1. Jan 9Introduced
  2. Jan 17Sent to Health Care
  3. Mar 6Heard in Health Care
  4. Jul 7Died when the session ended
All 4 actions, as published
  1. Jan 9First reading. Referred to Speaker's desk.House of Representatives
  2. Jan 17Referred to Health Care with subsequent referral to Ways and Means.House of Representatives
  3. Mar 6Public Hearing held.House of Representatives
  4. Jul 7In committee upon adjournment.House of Representatives